0001477932-23-003816.txt : 20230522 0001477932-23-003816.hdr.sgml : 20230522 20230522062924 ACCESSION NUMBER: 0001477932-23-003816 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 62 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230522 DATE AS OF CHANGE: 20230522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hawkeye Systems, Inc. CENTRAL INDEX KEY: 0001750777 STANDARD INDUSTRIAL CLASSIFICATION: PHOTOGRAPHIC EQUIPMENT & SUPPLIES [3861] IRS NUMBER: 830799093 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-56332 FILM NUMBER: 23942359 BUSINESS ADDRESS: STREET 1: 6605 ABERCORN STREET 2: SUITE 204 CITY: SAVANNAH STATE: GA ZIP: 31405 BUSINESS PHONE: 912-388-6720 MAIL ADDRESS: STREET 1: 6605 ABERCORN STREET 2: SUITE 204 CITY: SAVANNAH STATE: GA ZIP: 31405 10-Q 1 hwke_10q.htm FORM 10-Q hwke_10q.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q 

(Mark One)

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2023

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

 

For the transition period from ____________ to ____________

 

Commission file number: 000-56332

 

Hawkeye Systems, Inc.

(Exact name of small business issuer as specified in its charter)

 

Nevada

 

83-0799093

(State or other jurisdiction

 of incorporation or organization)

 

(IRS Employer

Identification No.)

 

6605 AbercornSuite 204

SavannahGA 31405

(Address of principal executive offices)

 

(912253-0375

(Registrants telephone number, including area code)

 

_______________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act

 

Title of Each Class

 

Trading

 Symbol(s)

 

Name of each Exchange

 on which registered

N/A

 

N/A

 

N/A

 

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes     ☒ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit). ☐ Yes ☒ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Non-accelerated Filer

Accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Yes     ☐ No

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No

 

The number of shares outstanding of each of the issuer’s classes of common equity as of May 22, 2023, was  5,477,222 shares of common stock.

 

 

 

 

Contents

 

 

 

 

Page

 

Part 1

FINANCIAL INFORMATION

 

3

 

 

 

 

 

 

Item 1

Financial Statements (unaudited)

 

3

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets as of March 31, 2023 (unaudited) and June 30, 2022 (audited)

 

3

 

 

 

 

 

 

 

Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2023 and 2022 (unaudited)

 

4

 

 

 

 

 

 

 

Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended March 31, 2023, and 2022 (unaudited)

 

5

 

 

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the three and nine months ended March 31, 2023 and 2022 (unaudited)

 

6

 

 

 

 

 

 

 

Notes to the Unaudited Condensed Consolidated Financial Statements

 

7

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

11

 

 

 

 

 

 

Item 4.

Controls and Procedures

 

13

 

 

 

 

 

 

Part II.

OTHER INFORMATION

 

18

 

 

 

 

 

 

Item 1

Legal Proceedings

 

20

 

 

 

 

 

 

Item 1A

Risk Factors

 

20

 

 

 

 

 

 

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

 

20

 

 

 

 

 

 

Item 3

Defaults Upon Senior Securities

 

20

 

 

 

 

 

 

Item 4

Mine Safety Disclosures

 

20

 

 

 

 

 

 

Item 5

Other Information

 

20

 

 

 

 

 

 

Item 6

Exhibits

 

21

 

 

 

 

 

 

 

SIGNATURES

 

22

 

 

 
2

Table of Contents

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

 

 

    March 31,

 

 

June 30,

 

 

 

2023

 

 

2022

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash

 

$499,690

 

 

$325

 

Accounts receivable

 

 

5,000

 

 

 

-

 

Prepaid expenses

 

 

5,925

 

 

 

1,333

 

Interest receivable

 

 

10,521

 

 

 

-

 

Loan receivable

 

 

200,000

 

 

 

-

 

Total current assets

 

 

721,136

 

 

 

1,658

 

 

 

 

 

 

 

 

 

 

Total assets

 

$721,136

 

 

$1,658

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable – related party

 

$672,573

 

 

$163,687

 

Accounts payable

 

 

16,384

 

 

 

7,637

 

Accrued liabilities – related party

 

 

30,218

 

 

 

22,322

 

Accrued interest – related party

 

 

217,835

 

 

 

79,946

 

Convertible note payable - related party

 

 

500,000

 

 

 

500,000

 

Line of credit - related party

 

 

525,000

 

 

 

265,000

 

Promissory Loan Payable – related party

 

 

700,000

 

 

 

-

 

    Common stock payable - related party

 

 

30,000

 

 

 

624,344

 

 

 

 

 

 

 

 

 

 

Total current liabilities

 

 

2,692,010

 

 

 

1,662,936

 

 

 

 

 

 

 

 

 

 

Loan payable to Eagle - JV partner

 

 

442,251

 

 

 

442,251

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

$3,134,261

 

 

$2,105,187

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies (Notes 5 to 9) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ deficit:

 

 

 

 

 

 

 

 

Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding

 

 

-

 

 

 

-

 

Common stock, $0.0001 par value, 400,000,000 shares authorized; 4,227,222 and 2,560,416 shares issued and outstanding, respectively (see Note 13)

 

$423

 

 

$256

 

Additional paid-in capital

 

 

9,377,727

 

 

 

8,778,391

 

Accumulated deficit

 

 

(11,791,275)

 

 

(10,882,176)

Total stockholders’ deficit

 

 

(2,413,125)

 

 

(2,103,529)

 Total liabilities and stockholders’ deficit

 

$721,136

 

 

$1,658

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
3

Table of Contents

 

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$-

 

 

$-

 

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

19,136

 

 

 

13,627

 

 

 

68,102

 

 

 

127,670

 

Management compensation

 

 

111,250

 

 

 

124,167

 

 

 

333,802

 

 

 

520,906

 

Professional fees

 

 

12,538

 

 

 

10,837

 

 

 

92,413

 

 

 

49,971

 

Professional fees - related party

 

 

250,000

 

 

 

15,500

 

 

 

292,415

 

 

 

167,758

 

Marketing

 

 

-

 

 

 

3,118

 

 

 

-

 

 

 

5,813

 

Total operating expenses

 

 

392,924

 

 

 

167,249

 

 

 

786,732

 

 

 

872,118

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(392,924)

 

 

(167,249)

 

 

(786,732)

 

 

(872,118)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income and expense:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Other income

 

 

5,000

 

 

 

-

 

 

 

5,000

 

 

 

-

 

PPP loan forgiveness

 

 

-

 

 

 

17,139

 

 

 

-

 

 

 

17,139

 

Interest income (expense)

 

 

10,521

 

 

 

-

 

 

 

10,521

 

 

 

(85)

Interest expense - related party

 

 

(50,308)

 

 

(43,799)

 

 

(137,888)

 

 

(107,602)

Total other expense

 

 

(34,787)

 

 

(26,660)

 

 

(122,367)

 

 

(90,548)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$(427,711)

 

$(193,909)

 

$(909,099)

 

$(962,666)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per common share - basic and diluted

 

$(0.10)

 

$(0.08)

 

$(0.22)

 

$(0.43)

Weighted average common shares outstanding - basic and diluted (1)

 

 

4,227,142

 

 

 

2,560,416

 

 

 

4,062,935

 

 

 

2,229,896

 

 

 

(1)

These quantities have been adjusted to reflect a 1-for-10 reverse stock split that became effective on February 9, 2023.

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
4

Table of Contents

 

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

 

For the nine months ended March 31, 2023

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Accumulated

 

 

 

 

 

Shares(1)

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Total

 

Balance, June 30, 2022

 

 

2,560,416

 

 

$256

 

 

$8,778,391

 

 

$(10,882,176)

 

$(2,103,529)

Common stock issued for common stock payable

 

 

1,666,667

 

 

 

167

 

 

 

594,177

 

 

 

-

 

 

 

594,344

 

Stock based compensation – options

 

 

-

 

 

 

-

 

 

 

5,159

 

 

 

-

 

 

 

5,159

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(215,096)

 

 

(215,096)

Balance, September 30, 2022

 

 

4,227,083

 

 

$423

 

 

$9,377,727

 

 

$(11,097,272)

 

$(1,719,122)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(266,292)

 

 

(266,292)

Balance, December 31, 2022

 

 

4,227,083

 

 

$423

 

 

$9,377,727

 

 

$(11,363,564)

 

$(1,985,414)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for rounding to reflect the 1 for 10 reverse stock split

 

 

139

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(427,711)

 

 

(427,711)

Balance, March 31, 2023

 

 

4,227,222

 

 

$423

 

 

$9,377,727

 

 

$(11,791,275)

 

$(2,413,125)

 

 

(1)

These quantities have been adjusted to reflect a 1-for-10 reverse stock split that became effective on February 9, 2023.

 

For the Nine Months ended March 31, 2022 (Restated)

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Accumulated

 

 

 

 

 

 

Shares(1)

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Total

 

Balance, June 30, 2021

 

 

1,792,115

 

 

$179

 

 

$7,958,622

 

 

$(9,713,661 )

 

$(1,754,860 )

Common stock issued for settlement of debt

 

 

30,000

 

 

 

3

 

 

 

29,997

 

 

 

-

 

 

 

30,000

 

Stock based compensation – options

 

 

-

 

 

 

-

 

 

 

73,994

 

 

 

-

 

 

 

73,994

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(311,355 )

 

 

(311,355 )

Balance, September 30, 2021

 

 

1,822,115

 

 

$182

 

 

$8,062,613

 

 

$(10,025,016 )

 

$(1,962,221 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common shares issued for stock payable

 

 

110,800

 

 

 

11

 

 

 

276,989

 

 

 

-

 

 

 

277,000

 

Cumulative-effect adjustment from adoption of ASU 2020-06

 

 

-

 

 

 

-

 

 

 

(169,354)

 

 

-

 

 

 

(19,627)

Stock based compensation - options

 

 

-

 

 

 

-

 

 

 

284,727

 

 

 

-

 

 

 

284,727

 

Stock option cashless exercised

 

 

603,501

 

 

 

61

 

 

 

(61)

 

 

-

 

 

 

-

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(486,842)

 

 

(486,842)

Balance, December 31, 2021

 

 

2,536,416

 

 

$254

 

 

 

8,452,632

 

 

$(10,362,131)

 

$(1,906,963)

Stock option cashless exercised

 

 

24,000

 

 

 

2

 

 

 

22

 

 

 

-

 

 

 

24

 

Stock based compensation - options

 

 

-

 

 

 

-

 

 

 

5,158

 

 

 

-

 

 

 

5,158

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(194,784)

 

 

(194,784)

Balance, March 31, 2022

 

 

2,560,416

 

 

$256

 

 

$8,609,821

 

 

$(10,706,642)

 

$(2,096,565)

 

(1)

These quantities have been adjusted to reflect a 1-for-10 reverse stock split that became effective on February 9, 2023.

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
5

Table of Contents

 

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

Nine Months Ended

 

 

 

March 31,

 

 

 

2023

 

 

2022

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$(909,099 )

 

$(962,666 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

PPP loan forgiveness

 

 

-

 

 

 

(17,139)

Stock based compensation – options and warrant

 

 

5,159

 

 

 

363,879

 

Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(5,000)

 

 

-

 

Prepaid expense

 

 

(4,592 )

 

 

(1,833 )

Interest receivable

 

 

(10,521 )

 

 

-

 

Accounts payable and accrued liabilities

 

 

8,747

 

 

 

51,475

 

Accounts payable and accrued liabilities - related party

 

 

516,782

 

 

 

83,160

 

Accrued interest - related party

 

 

137,889

 

 

 

44,710

 

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

(260,635 )

 

 

(438,414 )

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

   Note receivable from CNTNR

 

 

(200,000)

 

 

-

 

Net cash used in investing activities

 

 

(200,000)

 

 

-

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Net proceeds from line of credit – related party

 

 

260,000

 

 

 

-

 

    Net proceeds from promissory note – related party

 

 

700,000

 

 

 

-

 

    Net proceeds from convertible note - related party

 

 

-

 

 

 

175,000

 

Net cash provided by financing activities

 

 

960,000

 

 

 

175,000

 

 

 

 

 

 

 

 

 

 

Net change in cash

 

 

499,365

 

 

 

(263,414 )

Cash beginning of period

 

 

325

 

 

 

282,131

 

Cash end of period

 

$499,690

 

 

$18,717

 

 

 

 

 

 

 

 

 

 

Supplemental cash flow information

 

 

 

 

 

 

 

 

Cash paid for interest

 

$-

 

 

$-

 

Cash paid for taxes

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

 

 

 

 

 

Common stock issued exchanged for common stock payable – related party

 

$594,344

 

 

$-

 

Common stock issued exchanged for common stock payable

 

$-

 

 

$277,000

 

Replacement of Inventory financing payable to convertible note

 

$-

 

 

$500,000

 

Common stock issued for settlement of debt

 

$-

 

 

$30,000

 

Stock option cashless exercised

 

$-

 

 

$627

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

 

 
6

Table of Contents

 

HAWKEYE SYSTEMS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2023

 

Note 1 - Summary of Significant Accounting Policies

 

Business Overview

 

Hawkeye Systems, Inc. (the “Company”), a Nevada corporation incorporated on May 15, 2018. Our previous focus was on pandemic management products and services. We are currently seeking opportunities while actively trying to liquidate mask inventory and wind-up existing deals. The Company is currently looking for investment opportunities in diversified industries, such as affordable housing development, and technology applications to mitigate the effects of climate change. From inception until the date of this filing our activities have primarily consisted of (i) liquidating our stock of personal protective equipment (“PPE”) products, (ii) the development of our business plan and the evaluation of strategic investment and business development strategies, including the execution of letters of intent and the provision of funding to a few selected target companies, and (iii) recruiting and adding additional consultants and employees.

 

Basis of presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

 

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2022, as filed with the SEC on December 14, 2022.

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, valuation of beneficial conversion feature on convertible notes and the valuation allowance on deferred tax assets.

 

Accounts receivable and allowance for doubtful accounts

 

Accounts receivable consist of balances due from other income in the current quarter ended March 31, 2023, compared to no accounts receivable for the same period in 2022. As the historical trends in collectability is not available to derive an appropriate estimated allowance, the allowance for doubtful accounts was $0 as of March 31, 2023.

 

Fair value measurements

 

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

 

 
7

Table of Contents

 

Revenue recognition

 

As of March 31, 2023, the Company has generated revenues of $5,000 in consulting fees for an agreement with CNTNR. In the year ended June 30, 2022, the Company had no revenues. The revenue was recorded under other income. The consultant fees are payable on a monthly basis commencing March 1, 2023, pursuant to the agreement discussed in detail in Note 10 - Notes Receivable.  

 

The Company measures revenue within the scope of ASC 606 by applying the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. At contract inception, the Company assesses the goods or services promised within each contract that falls under the scope of ASC 606, determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied. The application of these five steps necessitates the development of assumptions that require judgment.

 

The Company records revenue based upon the consideration specified in the client arrangement, and revenue is recognized when the performance obligations in the client arrangement are satisfied.

 

Cost of sales

 

As of March 31, 2023, and 2022, the Company had no Cost of Sales.

 

Basic and diluted earnings per share 

 

Basic earnings per share are calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share are calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the nine months ended March 31, 2023, and 2022, potentially dilutive common stock equivalents were excluded from the calculation of diluted earnings per share because they were anti-dilutive as follows:

 

 

 

March 31,

 

 

March 31,

 

 

 

2023

 

 

2022

 

Warrants

 

 

239,400

 

 

 

249,400

 

Options

 

 

425,600

 

 

 

100,600

 

Convertible notes

 

 

6,208,130

 

 

 

3,575,000

 

Common stock payable

 

 

75,000

 

 

 

-

 

Total possible dilutive shares (See note 13)

 

 

6,948,129

 

 

 

3,925,000

 

 

The shares above have been adjusted to reflect a 1-for-10 reverse stock split that became effective on February 9, 2023. See further discussion on Note 13 – stock reverse split.

 

Recent Accounting Pronouncements

 

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed consolidated financial statements.

 

In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.

 

We early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method. Therefore, the condensed financial statements for the nine months ended March 31, 2023 are presented under the new standard, while the comparative period presented is not adjusted and continues to be reported in accordance with the Company’s historical accounting policy.

 

 
8

Table of Contents

  

Note 2 - Going Concern

 

The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the nine months ended March 31, 2023, the Company had a net loss of $909,099. As of March 31, 2023, the Company had an accumulated deficit of $11,791,275.

 

The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.

 

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company includes: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.

 

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

Note 3 – Restatement of Financial Statements for the Quarter End March 31, 2022

 

On July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Agreement, the interest of any net profits would be shared in a ratio of 33.3% among each member.  Upon the occurrence of any loss in some or all of the HIE’s capital, all members would be responsible to contribute capital to repay the loan, and additional contribution, with each party being responsible for 33.3% of the loss. 

 

Restatement Effect on Financial Statements

 

The Company did not receive any updates of the fiscal year 2021 financial statements from HIE until October, 2022. For the fiscal year ended June 30, 2021, HIE had a loan balance of $2,122,963 secured by Eagle, of which the Company has recognized 1/3 amounting to $707,654 as a guarantee of loan payable to Eagle - JV partner, the same amount as investment in HIE, as stipulated in the Membership Agreement. In addition, HIE incurred an operating loss of $1,385,962, which resulted in the Company recording 1/3 of its loss of $461,987 under other expenses on the statement of income to offset the investment in HIE as under equity method in accordance with FASB ASC 323.

 

As of March 31, 2022, the balance of investment in HIE was $245,667 and the balance of loan payable to Eagle - JV partner was $707,654. Since there were no operating activities or financial movement between July 1, 2021 to March 31, 2022, the investment in HIE and the loan payable to Eagle - JV partner are the same as of June 30, 2021.

 

 
9

Table of Contents

 

Effects on the previously issued year 2021 balance sheet referencing the restatement of asset, liability and equity are as follows:  

 

Balance Sheet at March 31, 2022:

 

 Originally

Reported

 

 

Restatement Adjustment

 

 

As

Restated

 

ASSETS

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

Cash

 

$18,717

 

 

$-

 

 

$18,717

 

Prepaid expenses

 

 

4,833

 

 

 

-

 

 

 

4,833

 

Total current assets

 

 

23,550

 

 

 

-

 

 

 

23,550

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment in HIE

 

 

-

 

 

 

245,667

 

 

 

245,667

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$23,550

 

 

$245,667

 

 

$269,217

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$282,277

 

 

$-

 

 

$282,277

 

Convertible note payable, net of discount - related party

 

 

1,175,000

 

 

 

-

 

 

 

1,175,000

 

Common stock payable - related party

 

 

200,000

 

 

 

-

 

 

 

200,000

 

Total current liabilities

 

 

1,657,277

 

 

 

-

 

 

 

1,657,277

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Loan payable due to Eagle - JV partner

 

 

-

 

 

 

707,654

 

 

 

707,654

 

PPP loan

 

 

-

 

 

 

-

 

 

 

-

 

Total liabilities

 

 

1,657,277

 

 

 

707,654

 

 

 

2,364,931

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ deficit:

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding

 

 

-

 

 

 

-

 

 

 

-

 

Common stock, $0.0001 par value, 400,000,000 shares authorized; 2,560,416, and 2,560,416 shares issued and outstanding, respectively

 

 

256

 

 

 

-

 

 

 

256

 

Additional paid-in capital

 

 

8,460,070

 

 

 

-

 

 

 

8,460,070

 

Accumulated deficit

 

 

(10,094,053)

 

 

(461,987)

 

 

(10,556,040)

Total stockholders’ equity deficit

 

 

(1,633,727)

 

 

(461,987)

 

 

(2,095,714)

   Total liabilities and stockholders’ deficit

 

$23,550

 

 

$

 

 

$269,217

 

 

Since there were no operating activities between July 01, 2021 to March 31, 2022, the previously issued March 31, 2022 Statement of Operations has not changed.

 

Note 4 – Joint Venture Investment in HIE LLC

 

On July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Agreement, the interest of any net profits would be shared 33.3% among each member.  If there is a loss in some or all of the capital, all members of HIE shall be responsible to contribute capital to repay the loan, and additional contribution, with each party being responsible for 33.3% of the loss. 

 

The joint venture investment in HIE LLC is accounted for by the Company using the equity method in accordance with FASB ASC 323.  There were no operating activities in HIE during the quarter ended March 31, 2023.

 

As of March 31, 2023, and June 30, 2022, the balances of investment in HIE were $0 in both periods.

 

 
10

Table of Contents

 

Note 5 – Loan payable due to Eagle - JV partner

 

On July 17, 2020, the Company entered into a Membership Agreement (See “Note 4 - Joint Venture Investment in HIE LLC ”). Under the terms and conditions of the Membership Agreement, in the event of a loss of capital of HIE, the Company is contingently liable to contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE.

 

In addition, the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle according to the membership agreement.  As of March 31, 2023, and December 31, 2022, the balances of loan payable to Eagle - JV partner totaled $442,251, and $707,654, respectively.

 

HIE had no operating activities for the nine months ended March 31, 2023. 

 

Note 6 – Convertible Notes Payable – related party     

 

On February 19, 2021, Steve Hall, an investor who holds approximately 72% of the Company’s common stock advanced $1 million to the Company. The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The creditor is 100% at risk as this is a non-recourse funding vehicle

 

In June 2021 the Company cancelled the contemplated purchase of inventory and returned $500,000 to Mr. Hall. Mr. Hall has agreed to allow the Company to retain the balance to fund future purchases and general operating expenses.

 

On October 1, 2021, the Company and Steve Hall entered into an agreement to replace the inventory financing payable of $500,000 with a convertible note with annual simple interest rate of 12% for the first 90 days and annual simple interest rate of 20% thereafter, with a due date on September 30, 2022. At the option of holder, this note is convertible, at any time, into shares of common stock at a conversion price of $0.02 per share.

 

The note’s maturity date was extended to September 30, 2023.

 

As of March 31, 2023, and June 30, 2022, the accrued interest under the note was $140,000, and $64,932, and the principal balance was $500,000 at the end of both quarters, respectively.

 

Note 7 – Line of Credit – related party

 

On October 1, 2021, Steve Hall agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter. The principal and interest payable shall be added to the principal amount of the agreement and payable pursuant to the same terms. The line of credit shall expire on October 1, 2022 unless renewed and/or extended by lender and borrower.  Subsequently, the line of credit has been renewed and extended with same terms and an expiration date of October 1, 2023.

 

As of March 31, 2023 and June 30, 2022, the outstanding principal totaled $525,000, and $265,000 with accrued interest of $75,566, and $15,015, respectively. 

 

 
11

Table of Contents

 

Note 8 – Promissory notes payable – related party

 

On March 29, 2023, Steve Hall provided the Company with a loan in the principal amount of $1,000,000, as evidenced by a promissory note with an annual interest rate of 12% per year (the “Steve Hall Note”). The purpose of the Steve Hall Note was to provide the Company with a funding source to make follow on investment in CNTNR USA Inc., a Delaware corporation (“CNTNR”). On May 31, 2023 (or upon the closing of a debt financing), the Company will repay the outstanding principal balance of the Steve Hall Note to the lender and transfer 90% of the shares of CNTNR, issued by CNTNR to the Company pursuant to the Company’s investment in CNTNR, plus 90% of the CNTNR Warrants as described below in Note 10 - Note Receivable.

 

As of March 31, 2023, the outstanding loan balance was $700,000 with accrued interest of $2,268.

 

 Note 9 – Accrued expenses – related party

 

Between September 2021 to September 2022, the Company had accepted deposits in the total of $30,218 from CNG. on a sale of face masks on behalf of Steve Hall, the CEO of Hawkeye Systems, Inc.  As of March 31, 2023, the deposits remain with the Company and has not been sent to Steve.  In addition, there are no fixed repayment terms or any repayment arrangement on this accrued liability.

 

Note 10 – Note receivable

 

On February 27, 2023, the Company entered into an initial promissory note with CNTNR and made an advanced payment of $200,000 to the borrower the following date.  Subsequently, on April 6, 2023, the Company restated the unsecured Promissory Note Agreement with CNTNR (the “CNTNR Note”) which superseded the prior agreement made in February 2023.  In the restated agreement, the Company agreed to lend CNTNR the total principal amount (“Principal Amount”) of $1,000,000 with a commitment fee equivalent to 5% of the Principal Amount.  CNTNR further agreed to pay the Company a monthly consulting fee of $5,000 beginning on March 1, 2023.  The balance of the consulting fee is recorded to the accounts receivable. 

 

The CNTNR Note has an annual interest rate of 12% and matures at the earlier of September 30, 2023, or the closing of a material debt or equity financing. Upon maturity of the note, CNTNR will pay to the Company all outstanding Principal Amount and interest plus outstanding consulting fee and issue the Company 10% of the issued and outstanding shares of CNTNR (equivalent to 6,170,879 shares).

 

Moreover, the CNTNR Note includes warrant coverage of one warrant for every share issued in repayment of the Principal Amount at the closing of an intended merger with CNTNR which is equal to 6,170,879 warrants. The warrants will have a 30% discount to the current fair market price when exercised and will expire 36 months after April 6, 2023. Both the shares and warrant shares have not been issued yet as of March 31, 2023 and will be recorded at fair value as financing income upon issuance at settlement.

 

As the interest is calculated on the total balance of $1,000,000 starting on the date of the first transfer on February 28, 2023, The CNTNR Note has accrued an interest of $10,521 with an outstanding principal of $200,000 as of quarter ended March 31, 2023.

 

Note 11 – Common stock payable – related party

 

On May 23, 2022, the board of directors granted Richard Cutler, former director who had resigned in August 2022, 50,000 shares (it was 500,000 shares prior to the reverse stock split described in Note 13) of restricted common stock valued at $20,000, with an exercise price of $0.4 per share.  The shares were granted as consideration for services granted.  All shares are restricted until an acquisition or reverse takeover of the Company.

 

On May 23, 2022, the board of directors granted Chris Mulgrew, Chief Financial Officer, 25,000 shares (it was 250,000 shares prior to the stock reverse split) of restricted common stock, valued at $10,000 with an exercise price of $0.04 per share.  The shares were granted as consideration for services granted.  All shares are restricted until an acquisition or reverse takeover of the Company.

 

As of March 31, 2023 and June 30, 2022, the Company reported common stock payable-related party of $30,000 and $624,343, which represents 75,000 (it was 750,000 shares prior to the stock reverse split), and 1,741,667 (it was 17,416,667 shares prior to the stock reverse split) shares of common stock to be issued, respectively. 

 

 
12

Table of Contents

 

Note 12 - Stockholders’ Equity

 

Common Stock

 

During the nine months ended March 31, 2023, the Company had the following common stock transactions:

 

 

·

1,666,667 shares issued on July 28, 2022 valued at $594,344 for settlement of two convertible notes to Steve Hall in aggregate amount of $500,000 and accrued interest of $94,344.

 

 

·

139 shares issued on February 9, 2023 with $0 value due to round up shares on stock reverse split. See note 13 for further discussion.

 

Stock Purchase Warrants

 

Transactions in stock purchase warrants for the nine months ended March 31, 2023 are as follows (the numbers set forth below have been adjusted to reflect the 1-for-10 reverse stock split of February 9, 2023):

 

 

 

Number of

 

 

Weighted

Average

Exercise

 

 

 

 Warrants

 

 

 Price

 

Balance at June 30, 2021

 

 

249,401

 

 

$1.00

 

Expired

 

 

-

 

 

 

-

 

Balance at September 30, 2022

 

 

249,401

 

 

$1.00

 

Expired

 

 

(10,000)

 

 

0.20

 

Balance at December 31, 2022

 

 

239,401

 

 

$1.04

 

Expired

 

 

-

 

 

 

-

 

Balance at March 31, 2023

 

 

239,401

 

 

$1.04

 

 

The composition of the Company’s warrants outstanding at March 31, 2023 are as follows:

 

Exercise Price

 

 

Number of Warrants

 

 

Weighted Average

Remaining Life (in years)

 

$

0.30

 

 

 

35,000

 

 

 

1.08

 

$

0.50

 

 

 

66,667

 

 

 

1.08

 

$

1.00

 

 

 

70,867

 

 

 

1.08

 

$

2.00

 

 

 

66,867

 

 

 

1.08

 

 

 

 

 

 

239,401

 

 

 

1.08

 

 

At March 31, 2023, the intrinsic value of the 239,401 outstanding warrant was $0.

 

 
13

Table of Contents

 

Stock Options

 

Transactions in stock options for the nine months ended March 31, 2023 are as follows:

 

 

 

Number of

options (1)

 

 

Weighted average

exercise price

 

 

Weighted average

remaining life

(in years)

 

Outstanding, June 30, 2022

 

 

425,600

 

 

 

0.14

 

 

 

4.41

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding, March 31, 2023

 

 

425,600

 

 

 

0.14

 

 

 

3.66

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, March 31, 2023

 

 

425,600

 

 

$0.14

 

 

 

3.66

 

 

 

(1)

These quantities have been adjusted to reflect a 1-for-10 reverse stock split that became effective on February 9, 2023.

 

During the nine months ended March 31, 2023 $5,159 was expensed to unrelated parties, and $0 remains unamortized.

 

At March 31, 2023, the intrinsic value of the 425,600 outstanding options was $0.

 

Note 13 – Stock Reverse Split

 

Hawkeye filed a form of 8K/A on March 23, 2023 announcing the Company amended its Articles of Incorporation to effect a one-for-ten reverse stock split (the “Reverse Split”) of the Company’s common stock while par value of $0.0001 per share remind the same. The Reverse Split was approved by FINRA on February 8, 2023, and became effective on February 9, 2023. All fractional shares resulting from the Reverse Split were rounded up to the nearest whole share, which results in an additional 139 shares issued for rounding. As a result of the Reverse Split, the Company now has approximately 4,227,222 shares of common stock outstanding. In addition, at the effective time of the reverse stock splits, all common shares, warrants, and options and the related financial information in this Quarterly Report on Form 10-Q were retroactively restated to reflect the 1-for-10 reverse stock split for all periods presented.

 

Note 14 – Consulting Agreement - Related Party  

 

On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, the Company’s CEO to provide real estate and development consulting services, including the supervision of the company's senior management, staff and all personnel, whether employees or consultants, strategic planning, property acquisitions and annual budget review.

 

 
14

Table of Contents

 

The contract period is 12 months with no option for renewal thereafter. The Company has paid Steve Hall a one-time flat service fee of $250,000. Compensation is without recourse and there is no requirement for performance of services during the term of the contract.

 

In addition, Steve agreed that the Company may defer payment until such time as there is sufficient liquidity in the Company. The Company agrees that should the company not have the ability to pay the amount due, Steve will be permitted to convert any unpaid balance into company stock at a conversion rate of the prevailing market rate minus 20%. In the event of a merger or acquisition, Steve will not be permitted to convert the outstanding balance until 90 days after the transaction has closed.

  

Note 15 - Subsequent Events 

 

Management has evaluated subsequent events through the date these financial statements were available to be issued. Based on our evaluation, that the following subsequent events would require disclosure in the financial statements:

 

 

·

On February 27, 2023, Hawkeye System, Inc. entered into an initial promissory note with CNTNR USA Inc (“CNTNR”)., a Delaware corporation and made an advanced payment of $200,000 to the borrower the following date. Subsequently, on April 12, 2023, the Company filed an 8K announcing that the Company entered into an unsecured Promissory Note Agreement with CNTNR effective April 06, 2023, whereby the Company will lend CNTNR $1,000,000 with a 5% Commitment Fee of the Principal Amount in the sum of $50,000 due upon signing. This Agreement supersedes the agreement dated 27 February 2023, and carries an annual interest rate of 12% and matures at the earlier of September 30, 2023, or the closing of a material debt or equity financing. Upon maturity of the loan, CNTNR will issue the Company one warrant for every share issued in repayment at the closing of an intended merger with CNTNR. The warrants will have a 30% discount to the current trading price when exercised and will expire 36 months after April 6, 2023. Furthermore, upon Maturity, CNTNR will pay, in cash, all outstanding principal and interest and issue 10% (6,170,879) of the issued and outstanding shares of CNTNR. As of the issued date of this report, the CNTNR Note has an outstanding principal of $790,000. In addition, CNTNR will pay the Company a monthly financial and administrative consulting fee of $5,000 starting March 01, 2023, and the accumulated outstanding balance is recorded in accounts receivable. Further detail see notes 10 - Note receivable.

 

 

 

 

·

As we stated in Note 8 - Promissory Notes Payable - Related Parties, as of March 31, 2023, the outstanding principal amount on the note was $700,000. On April 03, 2023, the company borrows an additional $300,000, bringing the outstanding balance to $1,000,000.

 

 

 

 

·

On April 24, 2023, the Company granted and issued 750,000 shares and 500,000 shares of common stocks to Corby Marshall, the CEO, and Christopher Mulgrew, the CFO, for compensation, respectively.

 

 
15

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

 

The following discussion relates to the historical operations and financial statements of Hawkeye Systems, Inc. for the nine months ended March 31, 2023.

 

Forward-Looking Statements

 

The following Management’s Discussion and Analysis should be read in conjunction with our financial statements and the related notes thereto included elsewhere in this quarterly report. The Management’s Discussion and Analysis contains forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect,” and the like, and/or future-tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements in this Annual Report. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the heading “Risks Factors” in our various filings with the Securities and Exchange Commission. We do not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this quarterly report.

 

The Company is currently looking for investment opportunities into target businesses in diversified industries, such as affordable housing development, and technology applications to mitigate the effects of climate change. From the date of our previous filing, we have executed a letter of intent with CNTNR for an investment and potential merger with such company, and committed to provide them with $1,000,000 in financing, as described in Notes 8 and 10 to the Financial Statements.

 

Financial Condition and Results of Operations

 

We have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operations.

 

We expect we will require additional capital to meet our long-term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

 

Results of Operations

 

Nine months ended March 31, 2023 compared to nine months ended March 31, 2022

 

We had no operating revenues, and cost of sales, for the nine months ended March 31, 2023, and 2022.  However, we generated $5,000 for the quarter ended March 31, 2023 in other income from CNTNR for consulting fees due to the agreement entered in February 2023. See further discussion on Note 10 – Note receivable.

 

Total operating expenses in the nine months ended March 31, 2023 were $786,731 compared to $872,118 for the same period in 2022. The decrease in operating expenses is primarily a result of decreased professional fees - related party, management compensation, and general and administrative expenses. The Company’s net loss was $909,099 for the nine months ended March 31, 2023 compared to $962,666 for the nine months ended March 31, 2022. The net loss for this period is primarily a result of operating expenses, and interest expense.

 

 
16

Table of Contents

 

Liquidity and Capital Resources

 

Our cash balance at March 31, 2023 was $499,690 compared to $325 at June 30, 2022. We do not believe these cash reserves are sufficient to cover our expenses for our operations for fiscal year ending March 31, 2024. We will require additional funding for our ongoing operations.

 

In addition, we intend to raise funds through the sale of equity and the exercise of warrants issued in private placements. Although to date we have had some warrant exercises for cash, there can be no assurance that we will be able to raise money through offerings or through the exercise of warrants. If we cannot raise any additional financing prior to the expiration of the first quarter of 2024, we believe we will be able to obtain loans from management in the future, if necessary, but have no agreement in writing.

 

We are a smaller reporting company and have accumulated losses to date. Under a limited operations scenario to maintain our corporate existence, we believe we will require additional funds over the next 12 months to complete our regulatory reporting and filings. However, we will require maximum participation through private placements, warrant exercises or alternative financings to implement our business plan.

 

There are no assurances that we will be able to obtain further funds required for our continued operations. Even if additional financing is available, it may not be available on terms we find favorable. Failure to secure the needed additional financing will have an adverse effect on our ability to remain in business.

 

Plan of Operation and Funding

 

We expect that working capital requirements will continue to be funded through equity offerings, warrant exercises, and related party advances in the near future. We have no guarantees or firm commitments that the related party advances will continue in the near future.

 

Existing working capital, further advances, together with anticipated capital raises are expected to be adequate to fund our operations over the next twelve months, but there is no guarantee that we will be successful in raising enough capital, or that we will receive the cash flow required to fund our operations. We have no lines of credit with banking institutions or other bank financing arrangements; however, we do have a convertible note (see Note 6 to the Financial Statements), a line a credit (see Note 7 to the Financial Statements), and a promissory note (see Note 8 to the Financial Statements), from a related party. Generally, we have financed operations to date through proceeds from the various loans as discussed on the Note 5 to Note 8 to the Financial Statements.

 

Management anticipates additional increases in operating expenses relating to: (i) developmental expenses; and (ii) legal and accounting fees, required to complete our filings with the SEC, or the closing of a potential merger or business combination with a target company. We intend to finance these expenses with issuances of securities and through the exercise of outstanding warrants.

 

Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences, or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to continue our operations.

 

Material Commitments

 

As of the date of this quarterly report, we have entered into various commitments on loan obligations.  For a discussion of the related items, please see Notes 5 to 10 to the Financial Statements.

 

Purchase of Significant Equipment

 

We do not intend to purchase any significant equipment during the next twelve months.

 

Off-Balance Sheet Arrangements

 

As of the date of this quarterly report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

 
17

Table of Contents

 

Going Concern

 

As reflected in the accompanying financial statements, the Company had an accumulated deficit of approximately $11,791,275 at March 31, 2023 and net loss from operations of $786,731.

 

The Company does not yet have a history of financial stability. Historically, the principal source of liquidity has been the issuance of equity securities and related party advances. In addition, the Company is in the development stage and has accumulated losses since inception. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The ability of the Company to continue operations is dependent on the success of Management’s plans and raising of capital through the issuance of equity securities, until funds provided by operations are sufficient to cover working capital requirements.

 

The Company will require additional funding to finance its operations as well as to identify, negotiate and materialize a business combination with a target business. The Company believes its current available cash may be insufficient to meet its cash needs for the near future. There can be no assurance that financing will be available in amounts or terms acceptable to the Company, if at all.

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Critical Accounting Policies and Estimates

 

For a discussion of our accounting policies and related items, please see the Notes to the Financial Statements, included in Item 2.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management’s Annual Report on Internal Control over Financial Reporting. 

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act).  Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes of accounting principles generally accepted in the United States.  In our review, we sought to find potential for material weaknesses in our financial controls, which is defined as a deficiency, or combination of deficiencies, in our accounting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Because of its inherent limitations, which include a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures, internal control over financial reporting may not prevent or detect misstatement, whether unintentional errors or fraud. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.

 

Our management, consisting of Corby Marshall as Chief Executive Officer and Christopher Mulgrew as Chief Financial Officer, reviewed and evaluated the effectiveness of the Company’s internal control over disclosure controls and procedures (as such term is defined in Rules 13a-15(3) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) and financial reporting as of March 31, 2023. In making this assessment, our management used the criteria described in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), as well as the guidance provided in SEC Release 33-8809. In such evaluation, Mr. Marshall and Mr. Mulgrew assessed daily interaction, self-assessment and other ongoing monitoring activities as evidence in the evaluation. Furthermore we sought to identify financial reporting risks, identify controls that adequately address financial reporting risks, considered entity level controls, reviewed the role of technology in our controls and reviewed the evidence available to support the assessment.

 

 
18

Table of Contents

 

Based on this evaluation, our management concluded that, as of March 31, 2023, our disclosure controls and our internal controls over financial reporting were not effective in recording, processing, summarizing and reporting on a timely basis information required to be disclosed in the reports that we file or submit under the Exchange Act and were not effective in assuring that information required to be disclosed in the reports we file or submit under the Exchange Act due to material weaknesses including (i) the Company having only two officers handling all financial transactions, (ii) lack of appropriate operational controls and consistency in providing our accounting personnel with financial information, (iii) incomplete financial statements on a daily basis and resulting errors in our underlying accounting system, (iv) lack of proper documentation of our assessment and evaluation, and (v) our determination that internal controls were ineffective due to the limited segregation of duties because of the limited management structure.

 

In response to that assessment we have made a determination that all accounting and financial reporting services should be outsourced to a qualified consulting firm, and we immediately engaged a new financial services provider.  We subsequently replaced that provider with an internal accounting contractor.

 

We have also made the determination that we need to dedicate more of the Company’s current and future financial resources to this function and engaged a permanent Chief Financial Officer.

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to rules of the SEC that permits us to provide only management’s report in this annual report.

 

Changes in Internal Control over Financial Reporting. 

 

Other than engaging a new financial services firm to provide financial statements, there were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
19

Table of Contents

 

PART II - OTHER INFORMATION

 

Item 1 - Legal Proceedings

 

We are not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this report, no director, officer, or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. We are not aware of any legal proceedings pending or that have been threatened against us or our properties.

 

From time to time the Company may be named in claims arising in the ordinary course of business. Currently, no legal proceedings or claims, are pending against or involve the Company that, in the opinion of management, could reasonably be expected to have a material adverse effect on its business and financial condition.

 

Item 1A - Risk Factors

 

Not required for Smaller Reporting Companies.

 

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds

 

No disclosure required.

 

Item 3 - Defaults Upon Senior Securities

 

No disclosure required.

 

Item 4 - Mine Safety Disclosure

 

No disclosure required.

 

Item 5 - Other Information

 

No disclosure required.

 

 
20

Table of Contents

 

Item 6 - Exhibits

 

Exhibits:

 

Number

 

Description

 

 

 

31.1*

 

Certification of Chief Executive Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant Section 302 of the Sarbanes Oxley Act of 2002

31.2*

 

Certification of Chief Financial Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant Section 302 of the Sarbanes Oxley Act of 2002

32.1*

 

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**

 

Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101*

 

Inline XBRL Document Set for the condensed consolidated financial statements and accompanying notes in Part I, Item 1, “Financial Statements” of this Quarterly Report on Form 10-Q.

104*

 

Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.

___________ 

* Filed herewith.

** Furnished herewith.

 

 
21

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Hawkeye Systems, Inc.

 

 

 

 

 

Date: May 22, 2023

By:

/s/ Corby Marshall

 

 

 

Corby Marshall, Chief Executive Officer

 

 

 

Principal Executive Officer

 

 

 

 

 

Date: May 22, 2023

By:

/s/ Christopher Mulgrew

 

 

 

Christopher Mulgrew, Chief Financial Officer

 

 

 

Principal Financial Officer

 

 

 
22

 

EX-31.1 2 hwke_ex311.htm CERTIFICATION hwke_ex311.htm

EXHIBIT 31.1

 

CERTIFICATION

 

I, Corby Marshall, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Hawkeye Systems, Inc. (the “Registrant”);

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

 

 

4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

 

 

 

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial; and

 

 

 

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 22, 2023

 

/s/ Corby Marshall

 

 

Corby Marshall

 

 

 

Chief Executive Officer

 

 

 

(Principal Executive Officer)

 

EX-31.2 3 hwke_ex312.htm CERTIFICATION hwke_ex312.htm

EXHIBIT 31.2

 

CERTIFICATION

 

I, Christopher Mulgrew, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Hawkeye Systems, Inc. (the “Registrant”);

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

 

 

 

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial; and

 

 

 

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 22, 2023

 

/s/ Christopher Mulgrew

 

 

Christopher Mulgrew

 

 

 

Chief Financial Officer

 

 

 

(Principal Financial Officer)

 

EX-32.1 4 hwke_ex321.htm CERTIFICATION hwke_ex321.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Hawkeye Systems, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Corby Marshall, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

 

Date: May 22, 2023

 

/s/ Corby Marshall

 

 

Corby Marshall

 

 

 

Chief Executive Officer

 

 

 

(Principal Executive Officer)

 

EX-32.2 5 hwke_ex322.htm CERTIFICATION hwke_ex322.htm

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Hawkeye Systems, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2023, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher Mulgrew, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

 

Date: May 22, 2023

 

/s/ Christopher Mulgrew

 

 

Christopher Mulgrew

 

 

 

Chief Financial Officer

 

 

 

(Principal Financial Officer)

 

EX-101.SCH 6 hwke-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - Restatement of Financial Statements for the Quarter End March 31, 2022 link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - Joint Venture Investment in HIE LLC link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - Loan payable due to Eagle - JV partner link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - Convertible Notes Payable related party link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - Line of Credit related party link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - Promissory notes payable - related party link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - Accrued expenses - related party link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - Note receivable link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - Common stock payable related party link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - Stockholders Equity link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - Stock Reverse Split link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - Consulting Agreement - Related Party link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - Restatement of Financial Statements for the Quarter End March 31, 2022 (Tables) link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - Stockholders Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - Restatement of Financial Statements for the Quarter End March 31, 2022 (Details) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - Restatement of Financial Statements for the Quarter End March 31, 2022 (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - Joint Venture Investment in HIE LLC (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000032 - Disclosure - Loan payable due to Eagle - JV partner (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000033 - Disclosure - Convertible Notes Payable - related party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000034 - Disclosure - Line of Credit related party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000035 - Disclosure - Promissory notes payable - related party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000036 - Disclosure - Accrued expenses - related party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000037 - Disclosure - Note receivable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000038 - Disclosure - Common stock payable related party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000039 - Disclosure - Stockholders Equity (Details) link:presentationLink link:calculationLink link:definitionLink 000040 - Disclosure - Stockholders Equity (Details 1) link:presentationLink link:calculationLink link:definitionLink 000041 - Disclosure - Stockholders Equity (Details 2) link:presentationLink link:calculationLink link:definitionLink 000042 - Disclosure - Stockholders Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000043 - Disclosure - Stock Reverse Split (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000044 - Disclosure - Consulting Agreement - Related Party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000045 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 7 hwke-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Ex Transition Period Entity Common Stock Shares Outstanding Document Quarterly Report Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Interactive Data Current Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Document Transition Report CONDENSED CONSOLIDATED BALANCE SHEETS ASSETS Current assets: Cash Accounts receivable Prepaid expenses Interest receivable Loan receivable Total current assets [Assets, Current] Total assets [Assets] LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Accounts payable - related party Accounts payable Accrued liabilities - related party Accrued interest - related party Convertible note payable - related party Line of credit - related party Promissory Loan Payable - related party Common stock payable - related party Total current liabilities [Liabilities, Current] Loan payable to Eagle - JV partner Total liabilities [Liabilities] Commitments and contingencies (Notes 5 to 9) Stockholders' deficit: Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding Common stock, $0.0001 par value, 400,000,000 shares authorized; 4,227,222 and 2,560,416 shares issued and outstanding, respectively (see Note 13) Additional paid-in capital Accumulated deficit Total stockholders' deficit [Stockholders' Equity Attributable to Parent] Total liabilities and stockholders' deficit [Liabilities and Equity] Preferred stock, shares par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sales Operating expenses: General and administrative Management compensation Professional fees Professional fees - related party Marketing Total operating expenses [Operating Expenses] Loss from operations [Operating Income (Loss)] Other income and expense: Other income PPP loan forgiveness Interest income (expense) Interest expense - related party [Interest Expense, Related Party] Total other expense [Other Nonoperating Income (Expense)] Net loss [Net Income (Loss) Attributable to Parent] Net loss per common share - basic and diluted Weighted average common shares outstanding - basic and diluted (1) CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) (Unaudited) Statement [Table] Statement [Line Items] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Balance, shares [Shares, Issued] Balance, amount Common stock issued for settlement of debt, shares Common stock issued for settlement of debt, amount Stock based compensation - options Net loss [Net Income (Loss), Including Portion Attributable to Noncontrolling Interest] Common shares issued for stock payable, shares Common shares issued for stock payable, amount Cumulative-effect adjustment from adoption of ASU 2020-06 Stock option cashless exercised, shares Stock option cashless exercised, amount Common stock issued for common stock payable, shares Common stock issued for common stock payable, amount Shares issued for rounding to reflect the 1 for 10 reverse stock split, shares Shares issued for rounding to reflect the 1 for 10 reverse stock split, amount Balance, shares Balance, amount CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: PPP loan forgivenes Stock based compensation - options and warrant Change in operating assets and liabilities: Accounts receivable [Increase (Decrease) in Accounts Receivable] Prepaid expense Interest receivable [Interest receivable] Accounts payable and accrued liabilities Accounts payable and accrued liabilities - related party Accrued interest - related party [Accrued interest - related party] Net cash used in operating activities [Net Cash Provided by (Used in) Operating Activities] Cash flows from investing activities: Note receivable from CNTNR [Proceeds from Sale of Notes Receivable] Net cash used in investing activities [Net Cash Provided by (Used in) Investing Activities] Cash flows from financing activities: Net proceeds from line of credit - related party Net proceeds from promissory note - related party Net proceeds from convertible note - related party Net cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Net change in cash [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect] Cash beginning of period [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents] Cash end of period Supplemental cash flow information Cash paid for interest Cash paid for taxes Non-cash investing and financing activities: Common stock issued exchanged for common stock payable - related party Common stock issued exchanged for common stock payable Replacement of Inventory financing payable to convertible note Common stock issued for settlement of debt Stock option cashless exercised Summary of Significant Accounting Policies Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Going Concern Going Concern Substantial Doubt about Going Concern [Text Block] Restatement of Financial Statements for the Quarter End March 31, 2022 Restatement of Financial Statements for the Quarter End March 31, 2022 [Restatement of Financial Statements for the Quarter End March 31, 2022] Joint Venture Investment in HIE LLC Joint Venture Investment in HIE LLC Investment [Text Block] Loan payable due to Eagle - JV partner Loan payable due to Eagle - JV partner [Loan payable due to Eagle - JV partner] Convertible Notes Payable related party Convertible Notes Payable - related party Line of Credit related party Line of Credit - related party Promissory notes payable - related party Promissory notes payable - related party [Promissory notes payable - related party] Accrued expenses - related party Accrued expenses - related party Related Party Transactions Disclosure [Text Block] Note receivable Note receivable [Note receivable] Common stock payable related party Common stock payable related party [Common stock payable related party] Stockholders Equity Stockholders' Equity Stock Reverse Split Stock Reverse Split [Stock Reverse Split] Consulting Agreement - Related Party Consulting Agreement - Related Party Collaborative Arrangement Disclosure [Text Block] Subsequent Events Subsequent Events Subsequent Events [Text Block] Business Overview Basis of presentation Use of estimates Accounts receivable and allowance for doubtful accounts Fair value measurements Revenue recognition Cost of sales Basic and diluted earnings per share Recent Accounting Pronouncements Schedule Of restatement of asset, liability and equity Schedule Of Basic and Diluted Earnings Per Share Transactions in stock purchase warrants Schedule of warrants outstanding Schedule Of Transactions in stock options Derivative Instrument Risk Axis Financial Instrument Axis Debt Instrument Axis Warrant [Member] Options [Member] Convertible Note [Member] Common Stock Payable [Member] Total Possible Dilutive Shares [Member] Total possible dilutive shares Allowance for doubtful account Revenue against consulting fees Net loss Accumulated deficit Restatement Axis Originally Reported [Member] Restatement Adjustment [Member] As Restated [Member] Cash [Cash and Cash Equivalents, at Carrying Value] Prepaid expenses Investment in HIE Accounts payable and accrued liabilities Convertible note payable, net of discount - related party Common stock payable - related party [Common stock payable - related party] Loan payable to Eagle - JV partner [Loan payable to Eagle - JV partner] PPP loan Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding Common stock, $0.0001 par value, 400,000,000 shares authorized; 2,560,416, and 2,560,416 shares issued and outstanding, respectively Additional paid-in capital Accumulated deficit Related Party Transaction [Axis] Lender [Member] Description of restatement effect on financial statements Other expenses Investment in HIE Loan due to Eagle Operating loss Plan Name Axis Joint Venture Investment LLC [Member] Investment Percentage of interest of any net profits in shares Percentage of additional contribution and if any losses Description of membership agreement Loan Payable Rate of Liable to contribute against origination loan Convertible Notes Payable - related party (Details Narrative) Description of related party transaction Repayment to related party Convertible note Annual simple interest for 90 days Annual simple interest thereafter Due date Conversion price of common stock Maturity date Accrued interest Principle balance Award Date Axis On October 1, 2021 Line of credit related party description Steve Hall [Member] Accrued interest payable Outstanding principal Line of credit related party description [Line of credit related party description] Expiry date of line of credit Loan principle amount Annual interest rate of loan Outstanding loan balance Accrued interest related party Related Party [Axis] Hawkeye Systems, Inc [Member] Accepted deposits Finite-Lived Intangible Assets by Major Class [Axis] CNTNR [Member] Accrued expense Outstanding pricipal balance Principal amount Commitment fees rate Advanced payment Monthly consulting fee Maturity date [Derivative, Maturity Date] Annual interest rate Interest amount Discripiton of warrants discount Chief Financial Officer[Member] Former Director [Member] Common stock payable - related party [Common stock payable - related party 1] Common stock to be issued Restricted Common stock Restricted Common stock value Conversion value Stock Purchase Warrants [Member] Warrant shares, Beginning [Class of Warrant or Right, Outstanding] Warrant shares, Expired [Warrant shares, Expired] Warrant shares, Ending Weighted average exercise price, Beginning Weighted average exercise price, Expired Weighted average exercise price, Ending Statement Class Of Stock Axis Warrants outsanding 1 [Member] Warrants outsanding 2 [Member] Warrants outsanding 3 [Member] Warrants outsanding 4 [Member] Warrants outsanding [Member] Number of Warrants Weighted Average Remaining Life (in years) Exercise Price Stock Options [Member] Number of options, beginning balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number] Number of options, Granted Number of options, ending balance Number of options, Exercisable Weighted Average Exercise Price, beginning balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price] Weighted Average Exercise Price, ending balance Weighted Average Exercise Price, Exercisable Weighted average remaining life, beginning Weighted average remaining life, ending Weighted average remaining life, exercisable Common stock shares issued upon settlement of debt Common stock value issued upon settlement of debt Aggregate amount of debt settled Accrued interest- debt settled Number of warrants/rights outstanding, intrisic value Number of warrants/rights outstanding Share based compensation expense Share based compensation expense, unamortized Stock Reverse Split [Member] Common stock par value Common stock, shares outstanding Description of stock reverse split Consulting Agreement [Member] Service fee Subsequent Event Type [Axis] Subsequent Event [Member] Corby Marshall [Member] Unsecured promissory note Outstanding pricipal balance Promissory notes payable Additional borrowing Outstanding Balance Common shares issued Shares Granted Discripiton of warrants Advanced payment Principal amount net Commitment fees rate Consulting fee Maturity date Annual interest rate EX-101.CAL 8 hwke-20230331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 9 hwke-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE